Healthcare & Life Sciences

Bringing Marketing Back In House

Biopharma Company

Summary

Outsourcing slowed execution and learning. The decision was optimize the vendor model or bring core capability in-house.

Moment

Vendor-led campaign execution became a constraint on speed, flexibility, and data control.

Tension

Keep working through vendors, or transition data and orchestration in-house without disrupting active programs.

Risk

A rushed transition could disrupt campaigns and degrade data quality. Staying outsourced would keep limiting speed and compounding cost.

Approach

We transitioned data and execution capabilities in-house, built a centralized audience foundation, configured orchestration, and established analytics for faster performance insight.

Outcome

Turnaround improved and vendor dependency dropped. Leadership gained a durable operating model built for speed, accuracy, and control.

More like this

Intake That Took Hours

Intake delays blocked care. The decision was optimize in-person workflows or redesign the model for virtual delivery.

Healthcare & Life Sciences · National Healthcare Provider

70,000 Claims a Month, By Hand

Claims volume exposed a manual bottleneck. The choice was rules automation or controlled AI with review.

Healthcare & Life Sciences · Medical Device Manufacturer

Acquisitions Without a Technology Map

Acquisition-led growth was adding risk faster than capability. Leadership needed a map before the next move.

Financial Services · National Investment Advisor

Facing a decision that needs an outside perspective?

Talk to Grizen